New Delhi, Jan 21 (PTI) Glenmark Pharmaceuticals on Tuesday said its US arm has launched anticoagulant Phytonadione injectable emulsion.

Glenmark Pharmaceuticals Inc., USA has launched Phytonadione injectable emulsion of strength 10 mg/mL single-dose ampules, the company said in a statement.

Also Read | Kolkata Fatafat Result Today: Kolkata FF Result for January 21, 2025 Declared, Check Winning Numbers and Result Chart of Satta Matka-Type Lottery Game.

The single-dose ampules is bioequivalent and therapeutically equivalent to the reference listed drug, Vitamin K1 Injectable Emulsion USP, 10 mg/mL of Hospira, Inc., it added.

Commenting on the launch, Glenmark President & Business Head, North America Marc Kikuchi said, it grows the company's "portfolio of products within the institutional channel, while also strengthening our commitment to bring to market quality and affordable alternatives for patients."

Also Read | Shillong Teer Results Today, January 21 2025: Winning Numbers, Result Chart for Shillong Morning Teer, Shillong Night Teer, Khanapara Teer, Juwai Teer and Jowai Ladrymbai.

Citing IQVIA data for the 12-month period ending November 2024, Glenmark said the Vitamin K1 Injectable Emulsion USP, 10 mg/mL market achieved annual sales of approximately USD 19.7 million in the US.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)